Loading company…
Sana Biotechnology, Inc. is a Seattle biotech developing engineered cells as medicines to treat disease.
Founded in 2018 and based in the US, Sana Biotechnology develops engineered cells as medicines and therapies for diseases. Its stated approach has three parts: repairing and controlling genes in any cell, replacing cells in the body, and removing barriers that limit access to these therapies. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in